Humasis (Korea) Top Management

205470 Stock  KRW 1,885  75.00  4.14%   
Humasis employs about 87 people. The company is managed by 7 executives with a total tenure of roughly 7 years, averaging almost 1.0 years of service per executive, having 12.43 employees per reported executive. Analysis of Humasis' management performance can provide insight into the company performance.
Jeong Cha  CEO
Chief Executive Officer, Director
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Humasis Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Humasis Management Team Effectiveness

The company has return on total asset (ROA) of 0.4052 % which means that it generated a profit of $0.4052 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 117.3403 %, meaning that it generated $117.3403 on every $100 dollars invested by stockholders. Humasis' management efficiency ratios could be used to measure how well Humasis manages its routine affairs as well as how well it operates its assets and liabilities.

Humasis Workforce Comparison

Humasis Co is number one stock in number of employees category among its peers. The total workforce of Health Care Equipment & Supplies industry is presently estimated at about 2,037. Humasis holds roughly 87.0 in number of employees claiming about 4% of equities under Health Care Equipment & Supplies industry.
The company has Profit Margin (PM) of 0.48 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.58 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.58.

Humasis Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Humasis Price Series Summation is a cross summation of Humasis price series and its benchmark/peer.

Humasis Notable Stakeholders

A Humasis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Humasis often face trade-offs trying to please all of them. Humasis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Humasis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jeong ChaChief Executive Officer, DirectorProfile
Gwang ChoDirectorProfile
Hyeong KimInternal AuditorProfile
Seong YimNon-Executive Independent DirectorProfile
Yin ChoNon-Executive Independent DirectorProfile
Jeong KimDirectorProfile
Seok LeeDirectorProfile

About Humasis Management Performance

The success or failure of an entity such as Humasis often depends on how effective the management is. Humasis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Humasis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Humasis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. HUMASIS is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of Humasis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Humasis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Humasis' management manipulating its earnings.

Humasis Workforce Analysis

Traditionally, organizations such as Humasis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Humasis within its industry.

Humasis Manpower Efficiency

Return on Humasis Manpower

Revenue Per Employee3.7B
Revenue Per Executive46B
Net Income Per Employee1.7B
Net Income Per Executive21.6B

Complementary Tools for Humasis Stock analysis

When running Humasis' price analysis, check to measure Humasis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humasis is operating at the current time. Most of Humasis' value examination focuses on studying past and present price action to predict the probability of Humasis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humasis' price. Additionally, you may evaluate how the addition of Humasis to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format